⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14296418 | 1.00 | — | — | |
| SCHEMBL878969 | 1.00 | — | — | |
| SCHEMBL10067945 | 0.94 | PRCP (0.44) | — | |
| SCHEMBL3957134 | 0.94 | PRCP (0.44) | — | |
| SCHEMBL8285912 | 0.94 | PRCP (0.44) | — | |
| SCHEMBL10067946 | 0.94 | PRCP (0.44) | — | |
| SCHEMBL7298202 | 0.92 | PRCP (0.42) | — | |
| SCHEMBL7299775 | 0.92 | PRCP (0.42) | — | |
| SCHEMBL31048387 | 0.92 | PRCP (0.42) | — | |
| SCHEMBL30973638 | 0.83 | PRCP (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584247-A2 | HETEROATOM SUBSTITUTED CYCLIC AND ALKYL AMINES AS ACTIVATORS OF SEROTONIN RECEPTORS | ATAI Therapeutics, Inc. (US) | 2025-07-16 | — | — | EP | disclosed |
| US-20240116896-A1 | HETEROATOM SUBSTITUTED CYCLIC AND ALKYL AMINES AS ACTIVATORS OF SEROTONIN RECEPTORS | ATAI THERAPEUTICS, INC. (US) | 2024-04-11 | — | — | US | disclosed |
| WO-2024054866-A2 | HETEROATOM SUBSTITUTED CYCLIC AND ALKYL AMINES AS ACTIVATORS OF SEROTONIN RECEPTORS | ATAI Life Sciences AG (DE) | 2024-03-14 | — | — | WO | disclosed |
| US-20240033320-A1 | IMMUNORHELIN COMPOUNDS FOR INTRACELLULAR INFECTIONS | ISR Immune System Regulation Holding AB (publ) (SE) | 2024-02-01 | — | — | US | disclosed |
| EP-3570866-B1 | NOVEL USE OF KNOWN COMPOUNDS- INTRACELLULAR INFECTIONS | ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL (SE) | 2023-05-10 | — | — | EP | disclosed |
| US-20230118205-A1 | NOVEL COMPOUNDS (IMMUNORHELINS) | ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL (SE) | 2023-04-20 | — | — | US | disclosed |
| US-11564969-B2 | Immunorhelin compounds for intracellular infections | ISR Immune System Regulation Holding AB (publ) (SE) | 2023-01-31 | — | — | US | disclosed |
| US-20220388980-A1 | QUINOLINE INHIBITORS OF RAD52 AND METHODS OF USE | UNIV DREXEL (US) | 2022-12-08 | — | — | US | disclosed |
| US-11434258-B2 | Compounds (immunorhelins) | ISR Immune System Regulation Holding AB (SE) | 2022-09-06 | — | — | US | disclosed |
| US-20220211860-A1 | PEPTIDE DERIVATIVES AND CONJUGATES THEREOF FOR TREATING CANCER | THE UNIVERSITY OF SYDNEY (AU) | 2022-07-07 | — | — | US | disclosed |
| WO-2011031904-A1 | HEPATITIS C VIRUS INHIBITORS | ENANTA PHARMACEUTICALS, INC (US) | 2011-03-17 | — | — | WO | disclosed |
| WO-2010148006-A1 | HEPATITIS C VIRUS INHIBITORS | ENANTA PHARMACEUTICALS, INC. (US) | 2010-12-23 | — | — | WO | disclosed |
| WO-2010132520-A1 | SPIRO 1,3,4-THIADIAZOLINE DERIVATIVES AS KSP INHIBITORS | SCHERING CORPORATION (US) | 2010-11-18 | — | — | WO | disclosed |
| US-20100226883-A1 | LINKED DIIMIDAZOLE DERIVATIVES | ENANTA PHARMACEUTICALS, INC. | 2010-09-09 | — | — | US | disclosed |
| US-20100221214-A1 | LINKED DIBENZIMIDAZOLE DERIVATIVES | ENANTA PHARMACEUTICALS, INC. | 2010-09-02 | — | — | US | disclosed |
| WO-2010096462-A1 | LINKED DIIMIDAZOLE DERIVATIVES | ENANTA PHARMACEUTICALS, INC (US) | 2010-08-26 | — | — | WO | disclosed |
| WO-2010091413-A1 | LINKED DIBENZIMIDAZOLE DERIVATIVES | ENANTA PHARMACEUTICALS, INC. (US) | 2010-08-12 | — | — | WO | disclosed |
| WO-2009052288-A1 | SPIRO-CONDENSED 1, 3, 4-THIADIAZOLE DERIVATIVES FOR INHIBITING KSP KINESIN ACTIVITY | SCHERING CORPORATION (US) | 2009-04-23 | — | — | WO | disclosed |
| US-7282510-B2 | Small molecule inhibitors of rotamase enzyme activity | GLIAMED, INC. (US) | 2007-10-16 | — | — | US | disclosed |
| US-20070218010-A1 | Contrast Agents for Magnetic Resonance Imaging | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2007-09-20 | — | — | US | disclosed |